BABY: Natus Medical Incorporated Instablogs

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Monday, March 11, 6:08 PM Natus Medical (BABY) appoints Jonathan Kennedy, former CFO of Intersil (ISIL), to the position of Senior Vice President and Chief Financial Officer. Comment! [Healthcare]
Thursday, February 28, 1:40 PM Natus Medical (BABY +8.5%) racks up a healthy gain on an upbeat FY13 forecast, and in spite of posting a mixed Q4 that beat on its EPS but missed on revenue. For Q1, the company sees EPS of $0.09 - $0.10 on revenues of $83M - $85M. Analysts are looking for $0.09 EPS on revenues of $83.94M. FY13 EPS is expected to be around $0.81 - $0.84 on revenues of $362M - $367M. The Street view is EPS of $0.82 on revenues of $359.02M. Comment! [Healthcare, Earnings, On the Move]
Thursday, February 28, 7:08 AM Natus Medical (BABY): Q4 EPS of $0.29 beats by $0.03. Revenue of $90.5M misses by $3.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, January 7, 2:14 PM Natus Medical (BABY +3.5%) has agreed to buy Astro-Med's (ALOT +1.8%) Grass Technologies Product Group for $18.6M in cash, in an effort to further expand its international presence. BABY says Grass will also add to its disposable product offerings and an entry into the research segment of the neurodiagnostic market. The deal is expected to close by the end of January. Comment! [Healthcare, On the Move]
Wednesday, November 7, 2012, 7:23 AM Natus Medical (BABY): Q3 EPS of $0.15 beats by $0.02. Revenue of $80.7M (+58.8% Y/Y) misses by $1M. (PR) Comment! [Earnings, Healthcare]
Thursday, July 26, 2012, 9:40 AM Natus Medical (BABY): Q2 EPS of $0.12 beats by $0.01. Revenue of $61M (+5% Y/Y) misses by $0.5M. (PR) Comment! [Earnings, Healthcare]
Thursday, April 26, 2012, 11:04 AM Natus Medical (BABY): Q1 EPS of $0.07 beats by $0.02. Revenue of $59.5M (flat Y/Y) beats by $1M. (PR) Comment! [Earnings, Healthcare]
Monday, April 23, 2012, 12:04 PM CareFusion (CFN -2%) sells its neurodiagnostic business, Nicolet, to Natus Medical (BABY +2.9%) for around $58M in an all cash deal. The sale is part of CFN's ongoing effort to control costs and streamline its businesses. Comment! [Healthcare, On the Move, M&A]
Tuesday, February 28, 2012, 8:04 AM Natus Medical (BABY): Q4 EPS of $0.14 beats by $0.02. Revenue of $64.1M (+1.4% Y/Y) misses by $0.8M. (PR) Comment! [Earnings, Healthcare]
Monday, October 10, 2011, 8:07 AM Natus Medical (BABY), a provider of systems for monitoring the health of newborns, warns its Q3 revenue will be roughly $51.5M ($50M exc. a recent acquisition), well below July guidance of $58M. Natus also expects Q4 EPS of $0.15, below a consensus of $0.19. The shortfall is blamed on weakness in the company's neurology business. Comment! [Healthcare, Earnings]
Friday, September 16, 2011, 11:53 AM Natus Medical (BABY +6.6%) pops after saying it's acquiring privately held Embla Systems, which makes devices used in diagnosing sleep apnea, for $16.1M in cash. Natus says the deal should add around $0.08 per share to its adjusted earnings in 2012. Comment! [Healthcare, M&A, On the Move]
Thursday, July 28, 2011, 11:41 AM Natus Medical (BABY), which had already preannounced a weak Q2, is down 12.2% after reporting Q2 revenue and non-GAAP EPS of $58.1M (+10% Y/Y) and $0.13, compared with a consensus of $57.9M and $0.14. The company now expects 2011 revenue of $236M and non-GAAP EPS of $0.58-$0.60, below prior guidance of $250M and $0.80-$0.81. Comment! [Healthcare, Earnings, On the Move]
Thursday, July 7, 2011, 10:33 AM Natus Medical (BABY -8.5%) sinks as its Q2 revenue falls short due to several large orders the company expected in late April failing to arrive. The firm expects to post revenue of ~$58M, well below its initial $62M to $64M forecast. Comment! [Healthcare, On the Move, Earnings]

BABY Natus Medical Incorporated

BABY

Natus Medical Incorporated